Heron Therapeutics
HRTX
HRTX
186 hedge funds and large institutions have $510M invested in Heron Therapeutics in 2022 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 60 increasing their positions, 46 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
22% more call options, than puts
Call options by funds: $593K | Put options by funds: $487K
7% more funds holding
Funds holding: 174 → 186 (+12)
6.34% more ownership
Funds ownership: 112.48% → 118.82% (+6.3%)
Holders
186
Holding in Top 10
3
Calls
$593K
Puts
$487K
Top Buyers
| 1 | +$36.1M | |
| 2 | +$23.5M | |
| 3 | +$13.2M | |
| 4 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$10.6M |
| 5 |
Millennium Management
New York
|
+$6.12M |
Top Sellers
| 1 | -$31.6M | |
| 2 | -$28.3M | |
| 3 | -$4.61M | |
| 4 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$4.42M |
| 5 |
CWG
C WorldWide Group
Copenhagen,
Denmark
|
-$3.35M |